Patent Owner's Notice of Appeal | Nov 30, 2018 | PAPER | PATENT OWNER |
Patent Owner's Statement Regarding Motion to Seal | Oct 17, 2018 | PAPER | PATENT OWNER |
FINAL WRITTEN DECISION AND RELATED ORDERS
Claims 1–17 Shown to Be Unpatentable
35 U.S.C. § 318(a); 37 C.F.R. § 42.73
Denying Patent Owner’s Motion to Amend
35 U.S.C. § 316(d); 37 C.F.R. § 42.121 | Oct 3, 2018 | PAPER | BOARD |
Petitioner Pfizer's Updated Mandatory Notices | Sep 25, 2018 | PAPER | PETITIONER |
Patent Owner's Updated Mandatory Notice | Sep 19, 2018 | PAPER | PATENT OWNER |
Errata to Order - Adjusting One-Year Pendency Due to Joinder - 35 USC 316 (a)(11); 37 CFR 42.100(c) | Jul 18, 2018 | PAPER | BOARD |
Order - Adjusting One-Year Pendency Due to Joinder | Jul 17, 2018 | PAPER | BOARD |
Petitioner Pfizers Updated Mandatory Notices | Jul 12, 2018 | PAPER | PETITIONER |
Hearing Transcript | Jun 20, 2018 | PAPER | BOARD |
Petitioners Reply in Support of Motion to Exclude Evidence | Jun 7, 2018 | PAPER | PETITIONER |
Patent Owner's Opposition to Motion to Exclude Evidence | Jun 4, 2018 | PAPER | PATENT OWNER |
Patent Owner's Updated Exhibit List | May 31, 2018 | PAPER | PATENT OWNER |
Petitioners Motion to Exclude Evidence | May 25, 2018 | PAPER | PETITIONER |
Petitioners Objections to Admissibility of Evidence | May 21, 2018 | PAPER | PETITIONER |
Email - Exhibit s2146 and 2147 | May 17, 2018 | EXHIBIT | BOARD |
Patent Owner's Objections to Demonstratives | May 16, 2018 | PAPER | PATENT OWNER |
Petitioners Responses to Observations on Cross Examination of Allan Lipton, M.D. | May 16, 2018 | PAPER | PETITIONER |
Petitioners Objections to Demonstrative Exhibits Served by Patent Owner | May 16, 2018 | PAPER | PETITIONER |
Motion for Observation on Cross Examination | May 14, 2018 | PAPER | PATENT OWNER |
Reply to Opposition to Motion to Exclude Evidence | May 14, 2018 | PAPER | PATENT OWNER |
Hsu | May 14, 2018 | EXHIBIT | PATENT OWNER |
Toxicity Manual | May 14, 2018 | EXHIBIT | PATENT OWNER |
Lipton Deposition Transcript | May 14, 2018 | EXHIBIT | PATENT OWNER |
Petitioners Reply to Patent Owners Opposition to Motion to Exclude Evidence | May 14, 2018 | PAPER | PETITIONER |
Petitioners Responses to Patent Owners Motion for Observations on Cross-Examination of Allan Lipton, M.D. and Robert Clarke, Ph.D., D.S.c. | May 14, 2018 | PAPER | PETITIONER |
Notice of Deposition | May 8, 2018 | PAPER | PATENT OWNER |
Granting Request for Oral Argument | May 7, 2018 | PAPER | BOARD |
Patent Owner's Motion for Observations on Cross Examination | May 7, 2018 | PAPER | PATENT OWNER |
Patent Owner's Opposition to Motion to Exclude Evidence | May 7, 2018 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence | May 7, 2018 | PAPER | PATENT OWNER |
Petitioners Opposition to Patent Owners Motion to Exclude Evidence | May 7, 2018 | PAPER | PETITIONER |
EXPUNGED | May 4, 2018 | PAPER | BOARD |
Petitioners Objections to Admissibility of Evidence [Corrected] | May 2, 2018 | PAPER | PETITIONER |
Patent Owner's Request for Oral Argument | Apr 30, 2018 | PAPER | PATENT OWNER |
Patent Owner's Motion to Exclude Evidence | Apr 30, 2018 | PAPER | PATENT OWNER |
Petitioners Request for Oral Argument | Apr 30, 2018 | PAPER | PETITIONER |
Petitioners Unopposed Motion to Seal | Apr 30, 2018 | PAPER | PETITIONER |
Petitioners Surreply to Patent Owners Contingent Motion to Amend | Apr 30, 2018 | PAPER | PETITIONER |
Surreply Declaration of Allan Lipton, M.D. [PUBLIC] | Apr 30, 2018 | EXHIBIT | PETITIONER |
Surreply Declaration of Allan Lipton, M.D. [PARTIES AND BOARD] | Apr 30, 2018 | EXHIBIT | PETITIONER |
Surreply Declaration of Robert Clarke, P.H.D., D.SC. [PUBLIC] | Apr 30, 2018 | EXHIBIT | PETITIONER |
Petitioners Motion to Exclude Evidence | Apr 30, 2018 | PAPER | PETITIONER |
Petitioners Objections to Admissibility of Evidence | Apr 27, 2018 | PAPER | PETITIONER |
PO's Reply ISO Contingent Motion to Amend | Apr 20, 2018 | PAPER | PATENT OWNER |
DeSantes_1992 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Clarke Deposition Transcript_04_10_2018 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Lipton Deposition Transcript_04_06_2018 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Pritchard_1997 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
DeGeorge_1998 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Tannock_1992 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
GenentechDocument_Genentech_0000034 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Supplemental Kerbel Declaration | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Supplemental Tannenbaum Decl | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Earhart Deposition Transcript_04_17_2018 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Rolan 1997 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Hsu_1997 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Wadler_1990 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Baselga_1998 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
VanPoznak_2002 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
GenentechDocument_GENENTECH__0000026-0000033 | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Supplemental Tannenbaum Decl | Apr 20, 2018 | EXHIBIT | PATENT OWNER |
Motion to Seal | Apr 20, 2018 | PAPER | PATENT OWNER |
Patent Owner's Objection to Evidence | Apr 6, 2018 | PAPER | PATENT OWNER |
Notice of Deposition of Robert Clarke, Ph.D. | Apr 2, 2018 | PAPER | PATENT OWNER |
Notice of Deposition of Allan Lipton, M.D. | Apr 2, 2018 | PAPER | PATENT OWNER |
Petitioners Opposition to Patent Owners Motion to Amend | Mar 30, 2018 | PAPER | PETITIONER |
Petitioners Reply to Patent Owners Response | Mar 30, 2018 | PAPER | PETITIONER |
Seidman et al., Memorial Sloan-Kettering Cancer Center Experience With Paclitaxel in the Treatment of Breast Cancer: From Advanced Disease to Adjuvant Therapy, 22(4) (Suppl. 8) SEMINARS IN ONCOLOGY 3-8 (1995) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Clarke, Animal Models of Breast Cancer: Their Diversity and Role in biomedical research, 39 Breast Cancer Res. & Treatment 1¿¿¿6 (1996) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Gianni, Future Directions of Paclitaxel-Based Therapy of Breast Cancer, 24(5) Seminars in Oncology S17-91-96 (1997) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Ellenberg et al., Surrogate Endpoints in Cinical Trials: Cancer, 8 Stat. in Med. 405¿¿¿13 (1989) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Transcript of the Deposition of Susan Tannenbaum, M.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Transcript of the Deposition of Susan Tannenbaum, M.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Transcript of the Deposition of Robert Kerbel, Ph.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Monmaney, T., A Lottery of Life, Death-and Hope, L.A. Times, Aug. 3, 1996, A1, A16-17 | Mar 30, 2018 | EXHIBIT | PETITIONER |
Transcript of the Deposition of Susan Desmond-Hellmann, M.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Seidman 1995 Library of Congress Copyright Record | Mar 30, 2018 | EXHIBIT | PETITIONER |
Holmes 1996 Library of Congress Copyright Record | Mar 30, 2018 | EXHIBIT | PETITIONER |
Petitioners Unopposed Motion to Seal | Mar 30, 2018 | PAPER | PETITIONER |
Petitioners Opposition to Patent Owners Motion to Amend | Mar 30, 2018 | PAPER | PETITIONER |
Petitioners Reply to Patent Owners Response | Mar 30, 2018 | PAPER | PETITIONER |
Holmes, Paclitaxel Combination Therapy in the Treatment of Metastatic Breast Cancer: A Review, 23(5) (Suppl. 11) Seminars in Oncology 46-56 (1996) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Kerbel, Human Tumor Xenografts as Predictive Preclinical Models for Anticancer Drug Activity in Humans, 2 4 Suppl. 1 Cancer Biology and Therapy S134-S139 (2003) | Mar 30, 2018 | EXHIBIT | PETITIONER |
U.S. Patent No. 6,949,245 | Mar 30, 2018 | EXHIBIT | PETITIONER |
Seidman et al., HER-2/neu Over-Expression and Clinical Taxane Sensitivity: A Multivariate Analysis in Patients with Metastatic Breast Cancer (MBC), 15 Proc. Am. Soc. Clin. Oncol. 104 (Abstract 80) (1996) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Ezzat et al., A Phase II Trial of Circadian-timed Paclitaxel and Cisplatin Therapy in Metastatic Breast Cancer, 8 Annals Oncology 663¿¿¿67 (1997) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Frasci et al., Weekly Paclitaxel-cisplatin Administration with G-CSF Support in Advanced Breast Cancer. A Phase II Study, 49 Breast Cancer Res. and Treatment 13¿¿¿26 (1998) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Klaassen et al., Phase II Study with Cisplatin and Paclitaxel in Combination with Weekly High-dose 24 h Infusional 5-fluorouracil/leucovorin for First-line Treatment of Metastatic Breast Cancer, 9 Anti-Cancer Drugs 203-07 (1998) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Reply Declaration of Allan Lipton, M.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Reply Declaration of Allan Lipton, M.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Reply Declaration of Robert Clarke, Ph.D. | Mar 30, 2018 | EXHIBIT | PETITIONER |
Transcript of the Deposition of Karen Gelmon, M.D. (IPR Nos. 2017-00804 and -00805) | Mar 30, 2018 | EXHIBIT | PETITIONER |
Gianni 1997 Library of Congress Copyright Record | Mar 30, 2018 | EXHIBIT | PETITIONER |
Ellenberg 1989 Library of Congress Copyright Record | Mar 30, 2018 | EXHIBIT | PETITIONER |
Monmaney 1996 Library of Congress Copyright Office Record | Mar 30, 2018 | EXHIBIT | PETITIONER |
Declaration of Benjamin A. Lasky | Mar 30, 2018 | EXHIBIT | PETITIONER |
U.S. Patent No. 7,740,841 | Mar 30, 2018 | EXHIBIT | PETITIONER |
Declaration of Christopher Lowden | Mar 30, 2018 | EXHIBIT | PETITIONER |
Patent Owner's Fifth Updated Mandatory Notices | Mar 29, 2018 | PAPER | PATENT OWNER |
Petitioner Pfizers Updated Notice of Deposition of Dr. Susan Desmond-Hellmann | Mar 15, 2018 | PAPER | PETITIONER |
Petitioner Pfizers Notice of Deposition of Dr. Susan Desmond-Hellmann | Feb 21, 2018 | PAPER | PETITIONER |
Joint Notice of Stipulation to Revised Schedule | Feb 14, 2018 | PAPER | PATENT OWNER |
Order Conduct of the Proceeding | Feb 13, 2018 | PAPER | BOARD |
Petitioner Pfizers Notice of Deposition of Robert Kerbel | Feb 12, 2018 | PAPER | PETITIONER |
Petitioner Pfizers Notice of Deposition of Susan Tannenbaum | Feb 12, 2018 | PAPER | PETITIONER |
Patent Owner's Fourth Updated Mandatory Notices | Feb 2, 2018 | PAPER | PATENT OWNER |
Decision Granting Pro Hac Vice Admission of Eric M. Majchrzak and Amit H. Thakore | Feb 1, 2018 | PAPER | BOARD |
Petitioner Pfizers Updated Mandatory Notices | Feb 1, 2018 | PAPER | PETITIONER |
Petitioner Samsung's Motion for Pro Hac Admission of Amit Thakore | Jan 29, 2018 | PAPER | PETITIONER |
Petitioners' First Amended Appendix of Exhibits | Jan 29, 2018 | PAPER | PETITIONER |
Petitioner Samsung's Motion for Pro Hac Admission of Eric Majchrzak | Jan 29, 2018 | PAPER | PETITIONER |
Declaration of Majchrzak in support of PHV Motion | Jan 29, 2018 | EXHIBIT | PETITIONER |
Declaration in Support of Motion for Pro Hac Admission of Amit Thakore | Jan 29, 2018 | EXHIBIT | PETITIONER |
Order - 37 C.F.R. 42.5 | Jan 24, 2018 | PAPER | BOARD |
Petitioner Pfizers Objections to Admissibility of Evidence | Jan 2, 2018 | PAPER | PETITIONER |
Patent Owner's Response | Dec 22, 2017 | PAPER | PATENT OWNER |
Deposition Transcript of Allan Lipton | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Witters 2003 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Hortobagyi 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Dr. Susan Tannenbaum | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Lewis 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Lewis 1993 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bastholt 1990 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Francia 2009 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Gura 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Clark 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Clarke 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Robert S. Kerbel, Ph.D. | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Szollosi 1995 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Thall 1995 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Wasserheit 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Stephanie Mendelsohn | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bissery 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Einzig 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Kardinal 1983 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bezwoda 1982 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Cavalli 1983 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bibby 1999 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Viloria 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
du Manoir 2006 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Francia 2008 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Ng 2006 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Klement 2002 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Kerbel 1991 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Buckstein 2014 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bender 2008 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Giovannella 1983 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bao 1994 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Clark 1991 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Boven 1992 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Inaba 1988a | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Inaba 1988b | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Fidler 1994 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Weiss 1992 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Guerin 2013 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Bani 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Kobayashi 1994 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Theodorescu 1993 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Wong 2010 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Mak 2014 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Paridaens 2000 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Symmans 1995 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Shak 1999 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Seidman 2002 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Genentech Press Release 1998 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Clark 1988 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Parker 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Stephanie Mendelsohn | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Amend | Dec 22, 2017 | PAPER | PATENT OWNER |
Venturini 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Taxol PDR 1995 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Plowman 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Simon 1989 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Thomas 2016 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Carter 1992 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Smith 2001 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Paik 1992 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Keefe 2002 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Sparano 1997 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
McCaskill-Stevens 1996 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Perez 1998 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Fiebig 1984 | Dec 22, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal | Dec 22, 2017 | PAPER | PATENT OWNER |
Patent Owner's Updated Mandatory Notices | Dec 11, 2017 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Dec 8, 2017 | PAPER | PETITIONER |
COPY ONLY of Order from Terminated IPR2017-01960 Granting Joinder with Joined IPR2017-00737 | Dec 1, 2017 | PAPER | BOARD |
Patent Owner's Second Amended Notice of Deposition of Allan Lipton, M.D. | Nov 28, 2017 | PAPER | PATENT OWNER |
Joint Notice of Stipulation to Revised Schedule | Nov 21, 2017 | PAPER | PETITIONER |
Patent Owner's Updated Mandatory Notices | Nov 16, 2017 | PAPER | PATENT OWNER |
Genentech Power of Attorney | Nov 16, 2017 | PAPER | PATENT OWNER |
Patent Owner's Amended Notice of Deposition of Allan Lipton, M.D. | Nov 10, 2017 | PAPER | PATENT OWNER |
Petitioner's Updated Mandatory Notices | Oct 20, 2017 | PAPER | PETITIONER |
Expunged | Oct 13, 2017 | PAPER | BOARD |
Patent Owner's Notice of Deposition of Allan Lipton, Ph.D. | Oct 4, 2017 | PAPER | PATENT OWNER |
Amended Scheduling Order | Oct 4, 2017 | PAPER | BOARD |
Petitioner's Response to Samsung Bioepis Co., Ltd.'s Motion for Joinder filed in IPR2017-01960 | Oct 2, 2017 | PAPER | PETITIONER |
Joint Notice of Stipulation to Revised Schedule | Sep 19, 2017 | PAPER | PETITIONER |
Decision Granting Petitioner's Motions for Pro Hac Vice Admission | Sep 12, 2017 | PAPER | BOARD |
Petitioner's Updated Power of Attorney | Sep 8, 2017 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Sep 8, 2017 | PAPER | PETITIONER |
Petitioners Motion for the Pro Hac Vice Admission of Sarah K. Tsou | Sep 8, 2017 | PAPER | PETITIONER |
Declaration of Sarah K. Tsou in Support of Petitioners Motion for the Pro Hac Vice Admission | Sep 8, 2017 | PAPER | PETITIONER |
Petitioners Motion for the Pro Hac Vice Admission of Benjamin A. Lasky | Sep 8, 2017 | PAPER | PETITIONER |
Declaration of Benjamin A. Lasky in Support of Petitioners Motion for the Pro Hac Vice Admission | Sep 8, 2017 | PAPER | PETITIONER |
Petitioners Motion for the Pro Hac Vice Admission of Christopher J. Citro | Sep 8, 2017 | PAPER | PETITIONER |
Declaration of Christopher J. Citro in Support of Petitioners Motion for the Pro Hac Vice Admission | Sep 8, 2017 | PAPER | PETITIONER |
Petitioners Motion for the Pro Hac Vice Admission of Mark C. McLennan | Sep 8, 2017 | PAPER | PETITIONER |
Declaration of Mark C. McLennan in Support of Petitioners Motion for the Pro Hac Vice Admission | Sep 8, 2017 | PAPER | PETITIONER |
Patent Owner's Objections to Evidence | Aug 10, 2017 | PAPER | PATENT OWNER |
Petitioner's Objections to Admissibility of Evidence | Aug 10, 2017 | PAPER | PETITIONER |
EXPUNGED | Jul 27, 2017 | PAPER | BOARD |
Excerpts of prosecution history of US Application No. 09/208,649 | Jul 27, 2017 | EXHIBIT | BOARD |
Scheduling Order | Jul 27, 2017 | PAPER | BOARD |
Decision
Instituting Inter Partes Review | Jul 27, 2017 | PAPER | BOARD |
Decision - Patent Owner's Motions for Pro Hac Vice Admission - 37 CFR 42.10 | Jun 21, 2017 | PAPER | BOARD |
Declaration of Daralyn J. Durie | Jun 8, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Lisa J. Pirozzolo | Jun 8, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Robert J. Gunther, Jr. | Jun 8, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Kevin S. Prussia | Jun 8, 2017 | EXHIBIT | PATENT OWNER |
Declaration of Andrew J. Danford | Jun 8, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Lisa J. Pirozzolo | Jun 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Robert J. Gunther, Jr. | Jun 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Daralyn J. Durie | Jun 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Kevin S. Prussia | Jun 8, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Admission Pro Hac Vice of Andrew J. Danford | Jun 8, 2017 | PAPER | PATENT OWNER |
PETITIONER¿¿¿S UPDATED MANDATORY NOTICES PURSUANT TO 37 C.F.R. ¿¿¿¿ 42.8(a)(3), (b)(1), and (b)(4)(i) | Jun 2, 2017 | PAPER | PETITIONER |
GNE H0648g Protocol | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE PDC Minutes - Private | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE PDC Minutes - Private | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE H0648g Final Report | May 2, 2017 | EXHIBIT | PATENT OWNER |
Hoyle 1998 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Inaba 1989 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner Preliminary Response | May 2, 2017 | PAPER | PATENT OWNER |
PO Motion to Seal | May 2, 2017 | PAPER | PATENT OWNER |
GNE PDC Minutes - Public | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE PDC Minutes | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE PDC Minutes - Public | May 2, 2017 | EXHIBIT | PATENT OWNER |
GNE Amend H0648g Protocol | May 2, 2017 | EXHIBIT | PATENT OWNER |
PO Prelim Response - Private | May 2, 2017 | PAPER | PATENT OWNER |
Harries and Smith 2002 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Holzman 2002 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Kola and Landis 2004 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Lehrer 1993 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Riethmuller 1992 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Doroshow 1996 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Modified Default Standing Protective Order - Redline | May 2, 2017 | EXHIBIT | PATENT OWNER |
Marsoni and Wittes 1984 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Mattern 1988 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Rowinsky 1991 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Slamon 2001 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Weiss 1990 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Yu 1996 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Junghans 1996 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Riethmuller 1993 | May 2, 2017 | EXHIBIT | PATENT OWNER |
Modified Default Standing Protective Order and PO's Certification of Agreement and Terms | May 2, 2017 | EXHIBIT | PATENT OWNER |
Reed 1996 | May 2, 2017 | EXHIBIT | PATENT OWNER |
PO Power of Attorney | Feb 10, 2017 | PAPER | PATENT OWNER |
PO Mandatory Notice | Feb 10, 2017 | PAPER | PATENT OWNER |
Errata | Feb 3, 2017 | PAPER | BOARD |
Notice of Accord Filing Date | Feb 2, 2017 | PAPER | BOARD |
PETITION FOR INTER PARTES REVIEW OF U.S. PATENT NO. 7,892,549 UNDER 35 U.S.C. 311 AND 37 C.F.R. 42.100 | Jan 20, 2017 | PAPER | PETITIONER |
Power of Attorney | Jan 20, 2017 | PAPER | PETITIONER |
U.S. Patent No. 7892549 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Assign. to Genentech filed in USPN 7846441 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Baselga 94_Anti-HER2 Humanized Monoclonal Antibody | Jan 20, 2017 | EXHIBIT | PETITIONER |
U.S. Patent No. 5677171 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Balsega 1994_Epidermal Growth Factor | Jan 20, 2017 | EXHIBIT | PETITIONER |
Declaration of Allan Lipton | Jan 20, 2017 | EXHIBIT | PETITIONER |
Presta 97_Humanization of an Anti-Vascular | Jan 20, 2017 | EXHIBIT | PETITIONER |
Carter 92_Humanization of an Anti-P185HER2 Antibody | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 01 | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 02 | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 03 | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 04 | Jan 20, 2017 | EXHIBIT | PETITIONER |
EP No. 1037926 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Hospira UK v. Genentech_UK Judgment-6-24-15 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Baselga 96_Phase II Study of Weekly Intravenous | Jan 20, 2017 | EXHIBIT | PETITIONER |
Balsega 97_HER2 Overexpression and Paclitaxel | Jan 20, 2017 | EXHIBIT | PETITIONER |
Drebin 88_Monoclonal Antibodies Reactive | Jan 20, 2017 | EXHIBIT | PETITIONER |
Pegram 95_Phase II Study of Intravenous Recombinant | Jan 20, 2017 | EXHIBIT | PETITIONER |
Nabholtz 2000_Results of Two Open-Label | Jan 20, 2017 | EXHIBIT | PETITIONER |
Hudziak 89_P185HER2 Monoclonal Antibody | Jan 20, 2017 | EXHIBIT | PETITIONER |
Phillips 2008_Targeting HER2-Positive Breast Cancer | Jan 20, 2017 | EXHIBIT | PETITIONER |
Phillips 2014_Dual Targeting of HER2-Positive Cancer | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 07 | Jan 20, 2017 | EXHIBIT | PETITIONER |
U.S. Provisional Patent Application No. 60069346 | Jan 20, 2017 | EXHIBIT | PETITIONER |
US Application No. 09208649 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Sorenson 90_Analysis of Events Associated | Jan 20, 2017 | EXHIBIT | PETITIONER |
Pietras 94_Antibody to HER2-2neu Receptor | Jan 20, 2017 | EXHIBIT | PETITIONER |
Walpole_The weight of nations | Jan 20, 2017 | EXHIBIT | PETITIONER |
Gelmon 96_Phase I-II Trial of Biweekly | Jan 20, 2017 | EXHIBIT | PETITIONER |
EP No. 1037926-UK Decision-6-13-16 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Declaration of Amanda Hollis | Jan 20, 2017 | EXHIBIT | PETITIONER |
Declaration of Christopher Lowden | Jan 20, 2017 | EXHIBIT | PETITIONER |
Sliwkowski Decl. - App. No. 09208649 | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 05 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Herceptin Development Timeline | Jan 20, 2017 | EXHIBIT | PETITIONER |
Nicolaou 96_Taxoids-New Weapons Against Cancer | Jan 20, 2017 | EXHIBIT | PETITIONER |
Slamon 87_Human Breast Cancer | Jan 20, 2017 | EXHIBIT | PETITIONER |
Slamon 89_Studies of the HER-2neu Proto-Oncogene | Jan 20, 2017 | EXHIBIT | PETITIONER |
DeVita 2008_A History of Cancer Chemotherapy | Jan 20, 2017 | EXHIBIT | PETITIONER |
Pegram 92_Monoclonal Antibody to HER-2neu Gene | Jan 20, 2017 | EXHIBIT | PETITIONER |
Pegram 97_Effect of HER-2neu Overexpression | Jan 20, 2017 | EXHIBIT | PETITIONER |
Shan 96_Anthracycline-Induced Cardiotoxicity | Jan 20, 2017 | EXHIBIT | PETITIONER |
Mendelsohn 97_Epidermal Growth Factor | Jan 20, 2017 | EXHIBIT | PETITIONER |
EPA Exposure Factors Handbook | Jan 20, 2017 | EXHIBIT | PETITIONER |
Jones 86_Replacing the Complementarity-determining | Jan 20, 2017 | EXHIBIT | PETITIONER |
Declaration of Simon Cohen | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Baselga 96 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Miller 81_Reporting Results of Cancer Treatment | Jan 20, 2017 | EXHIBIT | PETITIONER |
Johnson 85_Food and Drug Administration Requirements | Jan 20, 2017 | EXHIBIT | PETITIONER |
Hospira UK v. Genentech_UK Judgment-11-30-16 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Balsega 97 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Drebin 88 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Miller 81 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Presta 97 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Hudziak 89 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Carter 92 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Gelmon 96 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Slamon 87 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Slamon 89 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Nicolaou 96 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Pegram 92 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Shan 96 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Mendelsohn 97 | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Jones 86 | Jan 20, 2017 | EXHIBIT | PETITIONER |
FDA Approved Drug Products re Taxol | Jan 20, 2017 | EXHIBIT | PETITIONER |
LOC Record for Pegram 98 | Jan 20, 2017 | EXHIBIT | PETITIONER |
FDA Approved Label for Taxol 1998 | Jan 20, 2017 | EXHIBIT | PETITIONER |
Pegram 98_Phase II Study | Jan 20, 2017 | EXHIBIT | PETITIONER |
File History Patent No. 7892549-Vol. 06 | Jan 20, 2017 | EXHIBIT | PETITIONER |